Abstract
Combining IMGN632, a Novel CD123-Targeting Antibody Drug Conjugate with Azacitidine and Venetoclax Facilitates Apoptosis in Vitro and Prolongs Survival In Vivo in AML Models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have